Log In Get Started
Press Releases June 2, 2026 07:30 AM

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

Integra LifeSciences CFO to present at 2026 Jefferies Global Healthcare Conference

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
IART

Integra LifeSciences Holdings Corporation announced that its CFO, Lea Knight, will be presenting at the 2026 Jefferies Global Healthcare Conference on June 3, 2026. The presentation will be webcast live on the company's investor relations site.

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference
IART
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Integra LifeSciences is a global medical technology leader focused on neurosurgery and tissue reconstruction.
  • The CFO's presentation at a major healthcare conference provides insight into the company’s strategy and financials.
  • The webcast offers investors direct access to company updates and potential strategic plans.

PRINCETON, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief financial officer Lea Knight will present at the 2026 Jefferies Global Healthcare Conference on June 3, 2026 at 10:30am ET.

A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.

About Integra LifeSciences
Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies are trusted by healthcare professionals to deliver life-saving care. For our latest news and information, visit www.integralife.com.

Investor Relations:
Chris Ward
(609) 772-7736
[email protected]   

Media Contact:
Laurene Isip
(609) 208-8121
[email protected]

Integra LifeSciences Holdings Corporation


Risks

  • Market reaction is uncertain as the announcement relates primarily to a forthcoming presentation rather than new product launches or financial results.
  • Potential competitive pressure in the medical technology sector could impact business performance.
  • Economic or regulatory changes in healthcare markets may affect the company’s growth prospects.

More from Press Releases

Tenable Uses OpenAI GPT Cyber Models to Help Defenders Inspect Community-Built AI Components Sep 3, 2026 XTEND Reality Expansion Ltd. and JFB Construction Holdings Complete Business Combination, Raising $110 Million in Total Capital Sep 3, 2026 Freshworks Announces Inducement Grant under Listing Rule 5635(C)(4) of the Nasdaq Stock Market Sep 3, 2026 Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS Sep 3, 2026 Rogers and Quebecor Agree to New 12-Year Sublicensing Deal for National NHL Games in French Sep 3, 2026